257 related articles for article (PubMed ID: 18441389)
1. Insulin acutely upregulates protein expression of the fatty acid transporter CD36 in human skeletal muscle in vivo.
Corpeleijn E; Pelsers MM; Soenen S; Mensink M; Bouwman FG; Kooi ME; Saris WH; Glatz JF; Blaak EE
J Physiol Pharmacol; 2008 Mar; 59(1):77-83. PubMed ID: 18441389
[TBL] [Abstract][Full Text] [Related]
2. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
3. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.
Bonen A; Parolin ML; Steinberg GR; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ; Dyck DJ
FASEB J; 2004 Jul; 18(10):1144-6. PubMed ID: 15132977
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats.
Chabowski A; Chatham JC; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E675-82. PubMed ID: 16684853
[TBL] [Abstract][Full Text] [Related]
5. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
[TBL] [Abstract][Full Text] [Related]
7. Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss.
Corpeleijn E; Mensink M; Kooi ME; Roekaerts PM; Saris WH; Blaak EE
Obesity (Silver Spring); 2008 May; 16(5):1025-32. PubMed ID: 18309299
[TBL] [Abstract][Full Text] [Related]
8. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
[TBL] [Abstract][Full Text] [Related]
9. Effect of a 2-day very low-energy diet on skeletal muscle insulin sensitivity in obese type 2 diabetic patients on insulin therapy.
Jazet IM; Ouwens DM; Schaart G; Pijl H; Keizer H; Maassen JA; Meinders AE
Metabolism; 2005 Dec; 54(12):1669-78. PubMed ID: 16311102
[TBL] [Abstract][Full Text] [Related]
10. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm.
Chabowski A; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E781-9. PubMed ID: 15166001
[TBL] [Abstract][Full Text] [Related]
11. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
12. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview.
Holloway GP; Luiken JJ; Glatz JF; Spriet LL; Bonen A
Acta Physiol (Oxf); 2008 Dec; 194(4):293-309. PubMed ID: 18510711
[TBL] [Abstract][Full Text] [Related]
13. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
Smith AC; Mullen KL; Junkin KA; Nickerson J; Chabowski A; Bonen A; Dyck DJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E172-81. PubMed ID: 17374701
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
Benton CR; Koonen DP; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heikkila JJ; Bonen A
J Physiol; 2006 May; 573(Pt 1):199-210. PubMed ID: 16484294
[TBL] [Abstract][Full Text] [Related]
15. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.
Bruce CR; Thrush AB; Mertz VA; Bezaire V; Chabowski A; Heigenhauser GJ; Dyck DJ
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E99-E107. PubMed ID: 16464906
[TBL] [Abstract][Full Text] [Related]
16. Metabolic implications of dietary trans-fatty acids.
Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
[TBL] [Abstract][Full Text] [Related]
17. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus.
Blaak EE
Proc Nutr Soc; 2004 May; 63(2):323-30. PubMed ID: 15294050
[TBL] [Abstract][Full Text] [Related]
18. Effects of hyperinsulinemia on glucose and lipid transporter expression in insulin-sensitive horses.
Suagee JK; Corl BA; Hulver MW; McCutcheon LJ; Geor RJ
Domest Anim Endocrinol; 2011 Apr; 40(3):173-81. PubMed ID: 21292427
[TBL] [Abstract][Full Text] [Related]
19. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status.
Bruce CR; Anderson MJ; Carey AL; Newman DG; Bonen A; Kriketos AD; Cooney GJ; Hawley JA
J Clin Endocrinol Metab; 2003 Nov; 88(11):5444-51. PubMed ID: 14602787
[TBL] [Abstract][Full Text] [Related]
20. Regulation of fatty acid transport by fatty acid translocase/CD36.
Bonen A; Campbell SE; Benton CR; Chabowski A; Coort SL; Han XX; Koonen DP; Glatz JF; Luiken JJ
Proc Nutr Soc; 2004 May; 63(2):245-9. PubMed ID: 15294038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
